Polymorphism of drug substance. An economic challenge;Polymorphie von Arzneistoffen. Eine wirtschaftliche Herausforderung?

Pharmazeutische Industrie

Volumn 59, Issue 2, 1997, Pages 165-169

  Henck, Jan Olav ^a   Griesser, Ulrich J ^a   Burger, Artur ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMOXICILLIN; CAPTOPRIL; CARBAMAZEPINE; CIPROFLOXACIN; CYCLOSPORIN A; DICLOFENAC; ENALAPRIL; FLUOXETINE; MEVINOLIN; NIFEDIPINE; OMEPRAZOLE; RANITIDINE; SIMVASTATIN;

ANALYTIC METHOD; ARTICLE; CONFORMATION; CRYSTAL STRUCTURE; DRUG CONTROL; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; HUMAN; THERMODYNAMICS;

EID: 0030942345     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Burger, A., Griesser, U. J., Eur. J. Pharm. Biopharm. 37, 118 (1991)
2. Burger, A., Pharm. Intern. 3, 158 (1982)
3. Burger, A., in: Topics in Pharmaceutical Sciences, Breimer, D. D., Speiser, P. (Hrsg.), S. 347-358, Elsevier Science Publishers, Amsterdam-Oxford-New York (1983)
4. Cartwright, A. C., in: International Pharmaceutical Product Registration, Cartwright, A. C., Mathews, B. R. (Hrsg.), S. 206-245, Ellis Horwood, New York (1994)
5. McGilveray, I. J., in: International Pharmaceutical Product Registration, Cartwright, A. C., Mathews, B. R. (Hrsg.), S. 307-363, Ellis Horwood, New York (1994)
6. Commision Directive 91/507/EEC modifying the Annex to Council Directive 75/318/EEC, 19. July 1991, Part 2 C 1.
7. Commision of the European Communities: Guidelines on the Quality, Safety and Efficiacy of Medicinal Products for Human Use, Article 4.2.3.
8. Byrn, S., Pfeiffer, R., Ganey, M. et al., Pharm. Res. 12, 945 (1995)
9. Borka, L., Haleblian, J. K., Acta Pharm. Jugosl. 40, 71 (1990)
10. Burger, A., Ramberger, R., Mikrochim. Acta II, 259 (1979)
11. Grunenberg, A., Henck, J.-O., Siesler, H. W., Int. J. Pharm. 129, 147 (1996)
12. Burger, A., ØAZ 31, 1050 (1977)
13. Ramberger, R., Burger, A., Pröll, K., Sci. Pharm. 51, 198 (1983)
14. Burger, A., Ramberger, R., Schmidt, W., Pharmazie 35, 711 (1980)
15. Burger, A., Ramberger, R., Schmidt, W., Pharmazie 36, 41 (1981)
16. Burger, A., Brox, W., Ratz, A. W., Acta Pharm. Technol. 31, 231 (1985)
17. Giron, D., S.T.P. Pharma 4, 330 (1988)
18. Henck, J.-O., Diplom-Arbeit, Essen (1993)
19. Carstensen, J. T., Franchini, M. K., Drug Dev. Ind. Pharm. 21, 523 (1995)
20. Eckert, T., Müller, J., Arch. Pharm. 310, 116 (1977)
21. Burger, A., Koller; K. T., Sci. Pharm. 64, 293 (1996)
22. Ip, D. P., Brenner, G. S., Stevenson, J. M. et al., Int. J. Pharm. 28, 183 (1986)
23. Kuhnert-Brandstätter, M., Porsche, U., Sci. Pharm. 58, 55 (1990)
24. Reck, G., Faust, G., Dietz, G., Pharmazie 43, 771 (1988)
25. FDA, Guide to Inspections of Oral Solid Dosage Forms Pre/Post Approval Issues for Development and Validation (January 1994)
26. Kadin, H., Anal. Profiles of Drug Subst. 11, 79 (1982)